Mental Health Clinics in Albion, NY Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Albion Correctional Facility Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 3595 State School Rd, Albion, NY 14411 Phone: 585-589-5511 Fax: 585-589-7770 |
Annette M. Hertzlin-lockamyeir, Lcsw Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 27 S Platt St, Albion, NY 14411 Phone: 585-303-3724 Fax: 585-589-1036 |
Oak Orchard Community Health Center, Inc. Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 317 West Ave, Albion, NY 14411 Phone: 585-589-5613 Fax: 585-637-2375 |
News Archive
Researchers find gene regulator that plays key role in DS-AMKL
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
AFA welcomes inclusion of cognitive impairment screening in healthcare reform proposal
The Alzheimer's Foundation of America (AFA) today applauded Senate Finance Committee Chairman Max Baucus (D-MT) and Senator Tom Carper (D-DE), who spearheaded the provision, for including cognitive impairment screening for Medicare beneficiaries in Baucus' healthcare reform proposal, "America's Healthy Future Act of 2009."
GAO report looks at U.S. aid for food emergencies, iWatch reports
According to a GAO report issued last week, "the USAID program designed for food emergencies now spends more than half of its funding to cover multi-year shortages that have become the norm. About 96 percent of the food aid supplied in 2010 went to 21 countries that have received U.S. food aid for four years or more," iWatch News reports.
Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.
Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.
Vidacare to release results of validation study on its OnControl Bone Marrow System
Vidacare Corporation has completed an analysis and is releasing the results of a validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures.
› Verified 5 days ago